{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:36:57Z","timestamp":1793795817229,"version":"4.6.1"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"Importance<\/jats:title>Antibiotic allergy labels (AALs) impact patient health and perioperative outcomes. Antibiotic allergy delabeling could improve antibiotic prescribing and infection-related outcomes perioperatively.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess the feasibility and safety of antibiotic allergy assessment and delabeling in anesthesiologist-led preoperative assessment clinics and expand delabeling efforts outside of specialist allergy clinics.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This randomized clinical trial was a multicenter, phase 2 feasibility and safety trial conducted between December 14, 2020, and October 31, 2023, at outpatient preoperative anesthesiologist-led clinics at 3 tertiary hospitals in Melbourne, Australia. Participants were adults (age \u226518 years) with a reported \u03b2-lactam AAL likely to require intravenous antibiotic therapy for perioperative prophylaxis. Randomization was carried out on a 1:1 basis.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Enhanced allergy assessment by anesthesiologists using a smartphone application with a decision support algorithm adapted from a validated antibiotic allergy assessment tool. Risk scores guided antibiotic allergy testing: direct oral challenge (low risk) or skin testing followed by oral challenge (medium to high risk).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The 2 primary feasibility outcomes were the proportion of patients randomized to intervention who received intervention per protocol and proportion of patients consenting to participate out of all eligible. The primary safety outcome was the proportion of the intervention group experiencing an antibiotic-associated adverse event (AE) within 90 days postsurgery.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 150 patients enrolled, 74 were randomly assigned to receive the intervention and 76 to control. The median age was 67 years (range, 28-89 years); 78 (52%) were female and 72 (48%) were male. For feasibility of recruitment, 150 of 511 patients (29.4%; 95% CI, 25.4%-33.5%) with eligible AALs were enrolled. For feasibility of intervention delivery, 47 of 74 patients (63.5%; 95% CI, 51.5%-74.4%) randomized to intervention had allergy testing; 28 of 30 patients (93%) assessed as low risk and 19 of 44 patients (43%) assessed as moderate\/high risk proceeded to allergy testing. Antibiotic-related AE were reported in 4 of 74 intervention patients (5.4%, 95% CI, 1.5%-13.3%), 1 event was immune mediated (benign rash) without a delay to surgery. There was less restricted antibiotic use in the intervention group (6 patients; 10.7%) compared with the control group (10 patients; 17.9%).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>Low-risk \u03b2-lactam AAL were successfully evaluated and delabeled by anesthesiologists in the preoperative clinic using the intervention. The absence of severe AE after the intervention provides reassurance that antibiotic allergy delabeling can be achieved as part of a preoperative workup without delaying surgery and may improve the choice of preferred \u03b2-lactam prophylaxis.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>anzctr.org.au Identifier: ACTRN12620001295932<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamasurg.2025.0279","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:55:56Z","timestamp":1743008156000},"page":"518","source":"Crossref","is-referenced-by-count":16,"title":["Perioperative Penicillin and Cephalosporin Antibiotic Allergy Assessment and Testing"],"prefix":"10.1001","volume":"160","author":[{"given":"Joseph Francis","family":"De Luca","sequence":"first","affiliation":[{"name":"Department of Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Centre of Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vogrin","sequence":"additional","affiliation":[{"name":"Centre of Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Medicine (St Vincent\u2019s Health), University of Melbourne, Fitzroy, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha Elizabeth","family":"Holmes","sequence":"additional","affiliation":[{"name":"Centre of Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Infectious Diseases, at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma Kate","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Centre of Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Infectious Diseases, at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie Lee","family":"Waldron","sequence":"additional","affiliation":[{"name":"Centre of Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionnuala","family":"Cox","sequence":"additional","affiliation":[{"name":"Centre of Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Nazareth","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Guha","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ned","family":"Douglas","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Royal Melbourne Hospital, Parkvillle, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hardidge","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha Nicole","family":"Peel","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Anne","family":"Douglass","sequence":"additional","affiliation":[{"name":"Department of Medicine Royal Melbourne Hospital, The University of Melbourne, Parkvillle, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Forsyth","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Medicine Royal Melbourne Hospital, The University of Melbourne, Parkvillle, Victoria, Australia"},{"name":"Department of General Medicine, Royal Melbourne Hospital, Parkvillle, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Anthony","family":"Trubiano","sequence":"additional","affiliation":[{"name":"Centre of Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Infectious Diseases, at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10167","key":"soi250006r1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy.","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"soi250006r2","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/jac\/dkw008","article-title":"Antimicrobial allergy \u2018labels\u2019 drive inappropriate antimicrobial prescribing: lessons for stewardship.","volume":"71","author":"Trubiano","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"soi250006r3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/cid\/ciw462","article-title":"Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study.","volume":"63","author":"MacFadden","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"soi250006r4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/bcp.13830","article-title":"Antibiotic allergy labels in hospitalized and critically ill adults: a review of current impacts of inaccurate labelling.","volume":"85","author":"Moran","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"soi250006r5","doi-asserted-by":"publisher","first-page":"k2400","DOI":"10.1136\/bmj.k2400","article-title":"Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study.","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"issue":"7","key":"soi250006r6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5694\/mja15.01329","article-title":"Old but not forgotten: antibiotic allergies in general medicine (the AGM Study).","volume":"204","author":"Trubiano","year":"2016","journal-title":"Med J Aust"},{"issue":"3","key":"soi250006r7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study.","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"soi250006r8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk.","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"soi250006r9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/QCO.0000000000000006","article-title":"Antimicrobial stewardship\u2019s new weapon? a review of antibiotic allergy and pathways to \u2018de-labeling\u2019.","volume":"26","author":"Trubiano","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"soi250006r10","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/imj.16543","article-title":"Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network.","volume":"54","author":"Hannah","year":"2024","journal-title":"Intern Med J"},{"issue":"11","key":"soi250006r11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/imj.13221","article-title":"Return to sender: the need to re-address patient antibiotic allergy labels in Australia and New Zealand.","volume":"46","author":"Trubiano","year":"2016","journal-title":"Intern Med J"},{"issue":"3","key":"soi250006r12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw153","article-title":"Improving antimicrobial stewardship by antibiotic allergy delabeling: evaluation of knowledge, attitude, and practices throughout the Emerging Infections Network.","volume":"3","author":"Trubiano","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"soi250006r13","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/14787210.2020.1792775","article-title":"The democratization of de-labeling: a review of direct oral challenge in adults with low-risk penicillin allergy.","volume":"18","author":"Rose","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"soi250006r14","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.bja.2020.07.048","article-title":"DALES, Drug Allergy Labels in Elective Surgical patients: a prospective multicentre cross-sectional study of incidence, risks, and attitudes in penicillin de-labelling strategies.","volume":"125","author":"Savic","year":"2020","journal-title":"Br J Anaesth"},{"issue":"9S","key":"soi250006r15","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.arth.2017.01.012","article-title":"Screening for beta-lactam allergy in joint arthroplasty patients to improve surgical prophylaxis practice.","volume":"32","author":"McDanel","year":"2017","journal-title":"J Arthroplasty"},{"issue":"9","key":"soi250006r16","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/jac\/dkx171","article-title":"Optimizing preoperative prophylaxis in patients with reported \u00df-lactam allergy: a novel extension of antimicrobial stewardship.","volume":"72","author":"Vaisman","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"soi250006r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067653","article-title":"Study protocol for PREPARE: a phase II feasibility\/safety randomised controlled trial on PeRiopErative Penicillin AlleRgy TEsting.","volume":"13","author":"De Luca","year":"2023","journal-title":"BMJ Open"},{"issue":"3","key":"soi250006r18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jaip.2018.07.048","article-title":"Pathways to improved antibiotic allergy and antimicrobial stewardship practice: the validation of a beta-lactam antibiotic allergy assessment tool.","volume":"7","author":"Devchand","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"soi250006r19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063784","article-title":"Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol.","volume":"12","author":"Copaescu","year":"2022","journal-title":"BMJ Open"},{"issue":"6","key":"soi250006r20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00134-024-07448-x","article-title":"Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial.","volume":"50","author":"Rose","year":"2024","journal-title":"Intensive Care Med"},{"issue":"7","key":"soi250006r21","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.jaip.2019.05.037","article-title":"Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial.","volume":"7","author":"Mustafa","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"soi250006r22","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1016\/j.bja.2018.09.009","article-title":"Penicillin allergy de-labelling ahead of elective surgery: feasibility and barriers.","volume":"123","author":"Savic","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"soi250006r23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1017\/ice.2019.4","article-title":"Changing antibiotic resistance patterns for Staphylococcus aureus surgical site infections.","volume":"40","author":"Khamash","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"soi250006r24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/archinte.161.4.525","article-title":"Clostridium difficile\u2013associated diarrhea: a review.","volume":"161","author":"Mylonakis","year":"2001","journal-title":"Arch Intern Med"},{"key":"soi250006r25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijid.2016.02.016","article-title":"Clindamycin resistance among Staphylococcus aureus strains in Israel: implications for empirical treatment of skin and soft tissue infections.","volume":"46","author":"Stein","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"1","key":"soi250006r26","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlad015","article-title":"Low self-reported penicillin allergy in South Africa: implications for global public health response.","volume":"5","author":"Day","year":"2023","journal-title":"JAC Antimicrob Resist"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2832026\/jamasurgery_de_luca_2025_oi_250006_1747170520.63367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T15:02:30Z","timestamp":1747234950000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2832026"}},"subtitle":["The PREPARE Pilot Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2025.0279","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}